cemka > Publications > HĂ©matologie

Classer les publications sur l'année

  • Clinical and Economic Burden of Patients with Haemophilia A and B in France: Analysis of a Nationwide Claims Database

    FRENZEL L, BOUEE S, LILLIU H, CAHOREAU V, GIRAUD N, DELIENNE S, FAGNANI F, COTTIN J, BUREAU I, REYNAUD A, FAHFOUHI Y, COUMERT A, BEILLAT M, MAMMAR N, RUDANT J, LEBRETON A

    WFH ; 2025;31

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Costs and management of patients with hemophilia A in France: the Hemraude study.

    LAURENDEAU C, GOUDEMAND J, TROSSAERT M, POLACK B, VARIN R, GODARD C, HADIM F, DETOURNAY B.

    Eur J Health Econ. ; 2022;23(1):23-32

  • Économie de la santĂ©

    Cost-effectiveness of emicizumab vs bypassing agents in the prevention of bleeding episodes in haemophilia A patients with anti-FVIII inhibitors in France.

    POLACK B, TROSSAËRT M, COUSIN M, BAFFERT S, PRUVOT A, GODARD C.

    Haemophilia ; 2020;27(1)e1-e11

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Anemia Management Practice in French Hemodialysis Centers.

    ROTTEMBOURG J, URENA TORRES P, LE MONIES DE SAGAZAN H, SIRAJEDINE K, EMERY C, ZAKIN L, WERNLI J, MAHI L.

    Br J Med Med Res ; 2015;5(11):1338-1348

  • Pharmaco-EpidĂ©miologie

    Do two intravenous iron sucrose preparations have the same efficacy?

    ROTTEMBOURG J, KADRI A, LEONARD E, DANSAERT A, LAFUMA A

    Nephrol Dial Transplant ; 2011;26(10):3262-3267

  • Pharmaco-EpidĂ©miologie

    Do two intravenous iron sucrose preparations have the same efficacy ?

    ROTTEMBOURG J, KADRI A, LEONARD E, DANSAERT A, LAFUMA A

    2011 - Nephrol Dial Transplant ; 26 - 10 : 3262-3267